The neurobiology of cognition in schizophrenia.

  title={The neurobiology of cognition in schizophrenia.},
  author={Carol A. Tamminga},
  journal={The Journal of clinical psychiatry},
  volume={67 9},
Cognitive dysfunction in schizophrenia differs from cognitive dysfunction in neurodegenerative illnesses because it is associated with neuronal dysfunction and not neurodegeneration. Pharmacologically, potential targets for developing treatments may differ from cognition in dementing disorders. Several putative molecular targets for treating cognition in schizophrenia show promise, such as treatments that act on the D(1) receptor of the dopamine system; the 5HT(1A), 5HT(2A), and 5HT(6… CONTINUE READING